Auron Therapeutics

Focused Team. One Purpose.

Newton, United States · $87.8M raised

Employees
11–50
Business Model
B2B
Total Funding
$87.8M
Last Round
$27.0M Series BFeb 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Auron Therapeutics is a patient-centered, platform-powered oncology company developing therapies that target cell-state plasticity — the root driver of cancer and inflammatory disease. Its proprietary AURIGIN platform uses AI and single-cell genomics to identify novel drug targets. Lead program AUTX-703 is in clinical development for AML and other hematologic malignancies.

Summary

Auron Therapeutics is a Biotech company based in Newton, United States. It has raised $87.8M in total across 3 rounds, most recently a $27.0M Series B round in Feb 2025. Investors include DCVC (Data Collab), Arkin Bio Ventures and Polaris Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BFeb 2025
$27.0M

Sign up to see all 3 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Auron Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/auron-therapeutics"><img src="https://indexed.vc/api/badge/company/auron-therapeutics" alt="Auron Therapeutics on Indexed.vc" width="260" height="76" /></a>